Zurcher Kantonalbank (Zurich Cantonalbank) Avidity Biosciences, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $34.1 Billion
- Q4 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 27,459 shares of RNA stock, worth $798,507. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,459
Previous 21,370
28.49%
Holding current value
$798,507
Previous $981,000
18.65%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RNA
# of Institutions
257Shares Held
108MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11MShares$321 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.43MShares$274 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$251 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.11MShares$236 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$231 Million3.76% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.52B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...